| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |